Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001562180-24-006088
Filing Date
2024-08-07
Accepted
2024-08-07 16:05:00
Documents
2
Period of Report
2024-08-05

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 5363
2 POA2024 kiguchipoa.txt EX-24 1821
  Complete submission text file 0001562180-24-006088.txt   8599
Mailing Address 100 FOXBOROUGH BOULEVARD SUITE 240 FOXBOROUGH MA 02035
Business Address
IGUCHI KIMI (Reporting) CIK: 0001304815 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36544 | Film No.: 241183534

Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address 215 FIRST STREET CAMBRIDGE MA 02142 617-299-8380
Sage Therapeutics, Inc. (Issuer) CIK: 0001597553 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)